59 completed, 7 unknown, 5 not yet recruiting, 5 withdrawn. 32 Phase 4, 21 Phase 3, 6 Phase 2, 5 Not applicable, 1 Phase 1.
Follow Hepatitis A: new trials by email Literature Review of Hepatitis A trials Research Report on Hepatitis A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Risk Factors and Outcomes of Hepatitis A in Children Hepatitis A, Acute Hepatitis | Not yet recruiting | Assiut University | 190 | 2026-09-26 | 2026-09-30 | |
| Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine Healive®, Havrix® - Hepatitis A | Recruiting | Sinovac Biotech Co., Ltd | 106 | 2026-08-02 | 2026-10-22 | |
| Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis Ursodeoxycholic Acid, Supportive Care - Hepatitis A, Hepatitis E Virus Infection | Not applicable | Not yet recruiting | Combined Military Hospital, Pakistan | 88 | 2026-04-01 | 2026-04-13 |
| the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines Polio, Measles | Not yet recruiting | China National Biotec Group Company Limited | 600 | 2026-01-30 | 2026-01-14 | |
| A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vaccine Inactivated HAV vaccine, Attenuated live HAV vaccine - Hepatitis A | Completed | Sinovac Biotech Co., Ltd | 105 | 2026-01-13 | 2026-10-02 | |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Immunity With Acute Hepatits A Hepatitis A, Hepatitis A Virus | Not yet recruiting | Assiut University | 50 | 2025-10-01 | 2025-04-24 | |
| Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents Hepatitis A, Hepatitis A Virus | Active not recruiting | Chiang Mai University | 60 | 2025-06-26 | 2026-05-22 | |
| Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV Inactivated hepatitis A vaccine (I-HAV) - Hepatitis A, Hepatitis A Virus | Phase 3 | Active not recruiting | Chiang Mai University | 36 | 2025-05-25 | 2026-05-22 |
| Phase IV Study of Concomitant Administration of the sIPV and HepA sIPV (booster dose at 18 months of age), HepA-L, HepA-I - Polio, Hepatitis A | Phase 4 | Not yet recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2000 | 2024-06-15 | 2024-06-14 |
| Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents Mevac-A vaccine, Havrix 720 Junior - HAV, Hepatitis A | Phase 3 | Completed | Chiang Mai University | 120 | 2024-04-27 | 2025-05-04 |
| Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis HAVRIX - Cirrhosis, Hep A | Phase 4 | Unknown | Mahidol University | 50 | 2024-02-29 | 2024-03-19 |
| Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination. Hepatitis A Vaccine - Hepatitis A | Phase 4 | Unknown | Best Healthcare Inc. | 300 | 2024-01-01 | 2023-12-28 |
| Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People 2 doses of HAV, At least one dose of HAV - Hepatitis A, Immunodeficiency | Phase 4 | Completed | LiuZhou People's Hospital | 392 | 2023-12-19 | 2025-12-31 |
| Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old Healive (hepatitis A vacine(human diploid cell), inactivated) - Hepatitis A | Phase 4 | Active not recruiting | Sinovac Biotech Co., Ltd | 1092 | 2023-10-24 | 2024-08-21 |
| To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL, HAVRIX 720 Junior 0.5 mL - Hepatitis A, Hep A | Phase 3 | Unknown | Boryung Biopharma Co., Ltd. | 106 | 2022-12-01 | 2022-11-14 |
| Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021 questionnaire - Cirrhosis | Completed | Centre Hospitalier Sud Francilien | 742 | 2021-09-27 | 2026-05-22 | |
| What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 Years Blood test - Hepatitis A | Completed | University of Lausanne Hospitals | 50 | 2019-10-06 | 2022-08-23 | |
| Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men POL arm, Comparison arm - Meningitis, HPV - Anogenital Human Papilloma Virus Infection | Not applicable | Withdrawn | Ann & Robert H Lurie Children's Hospital of Chicago | 2018-09-01 | 2019-07-23 | |
| Seroepidemiology of Viral Hepatitis in Hong Kong No intervention - Viral Hepatitis | Completed | Chinese University of Hong Kong | 2888 | 2018-09-01 | 2023-02-08 |
Showing 20 of 82. Sign in to see all of them.
Hepatitis B (23) · Hepatitis (13) · Chickenpox (5) · Measles (5) · Mumps (4) · Rubella (4) · Vaccine-Preventable Diseases (4) · Encephalitis, Japanese (3) · HIV Infections (3) · Poliomyelitis (3) · Whooping Cough (3) · Enterovirus Infections (2) · Fibrosis (2) · Hepatitis C (2)
Infections (82) · Digestive System Diseases (81) · Hepatitis, Viral, Human (81) · Liver Diseases (81) · Picornaviridae Infections (81) · RNA Virus Infections (81) · Virus Diseases (81) · Enterovirus Infections (80) · Hepatitis (69) · DNA Virus Infections (28) · Blood-Borne Infections (27) · Communicable Diseases (27) · Hepadnaviridae Infections (23) · Bacterial Infections (8) · Bacterial Infections and Mycoses (8)
Hepatitis A Vaccines (29) · twinrix (8) · Blood Specimen Collection (6) · Engerix-B (6) · Hepatitis B Vaccines (4) · Chickenpox Vaccine (3) · epaxal berna (3) · Data Collection (2) · Japanese Encephalitis Vaccines (2) · Aging (1) · Community-Institutional Relations (1) · Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · Fluzone High-Dose (1) · Freeze Drying (1) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1)
GlaxoSmithKline (27) · Sinovac Biotech Co., Ltd (8) · Sanofi Pasteur, a Sanofi Company (6) · Chiang Mai University (3) · Crucell Holland BV (3) · Assiut University (2) · Centers for Disease Control and Prevention (2) · China National Biotec Group Company Limited (2) · Institute of Medical Biology, Chinese Academy of Medical Sciences (2) · Aalborg University Hospital (1) · Ain Shams University (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Asan Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Best Healthcare Inc. (1)
China (17) · Belgium (15) · Thailand (7) · United States (7) · Czechia (6) · Germany (3) · South Korea (3) · Australia (2) · France (2) · Mexico (2) · Brazil (1) · Cambodia (1) · Canada (1) · Chile (1) · Costa Rica (1)
Natchaya Kunanitthaworn, MD (3) · Tavitiya Sudjaritruk, MD, PhD (3) · Fubao Ma (2) · Ahlam B Ali, prof (1) · Allan Hildesheim, Ph.D. (1) · Amy K Johnson, PhD (1) · Andre Vertruyen, MD (1) · Beth P Bell, MD, MPH (1) · Brian McMahon (1) · Chien-Ching Hung (1) · Christine H Lee, MD (1) · Claude Flamand, Ph.D. (1)
PMID 32710245, PMID 21366801, PMID 24508042, PMID 26190091, PMID 11855555, PMID 16708058, PMID 17259872, PMID 17947390, PMID 17980513, PMID 18233994, PMID 20630640, PMID 20856164, PMID 21241735, PMID 22537990, PMID 22777096, PMID 24284413, PMID 24656175, PMID 25483566, PMID 25969561, PMID 26346155, PMID 26770041, PMID 27093164, PMID 27105563, PMID 27686833, PMID 27815383, PMID 28060048, PMID 28319454, PMID 28507927, PMID 28887164, PMID 30030693, PMID 30144521, PMID 30370918, PMID 30673992, PMID 31282539, PMID 32307279, PMID 33110280, PMID 33303216, PMID 33753433, PMID 33990999, PMID 34222044, PMID 37036404, PMID 37243166, PMID 37252544, PMID 37833325, PMID 38138042, PMID 38637212, PMID 39165801, PMID 39810097, PMID 40391688, PMID 7847285
R01AI130398 (1), R01DA017476 (1)